Sam Samad

Mr. Samad joined Quest Diagnostics from Illumina, Inc., where he previously served as Chief Financial Officer since 2017. At Illumina, a global leader in DNA sequencing and array-based technologies, he had responsibility for the company's finance, accounting, investor relations, internal audit, and treasury functions.

Before joining Illumina, Mr. Samad held several senior leadership positions at Cardinal Health, including SVP and Corporate Treasurer. During his tenure as Treasurer, he also had operational and financial responsibility for Cardinal Health's China business. He previously served as SVP and CFO for Cardinal Health's $85 billion pharmaceutical segment, among other leadership roles. Prior to Cardinal Health, he spent 13 years at Eli Lilly and Company in a variety of sales and finance roles, both domestically and internationally, including as CFO of the company's Canada affiliate. Mr. Samad holds a BBA degree from the American University of Beirut in Lebanon and an MBA from McMaster University in Canada.